Professor, Medicine, Indiana University School of Medicine
Hematology
Dr. Lawrence H. Einhorn, MD
|
|
Give Review
Lawrence Einhorn is an expert in the field of Hematology. He studied medicine at Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Indianapolis Monthly", "Fellow (FASCO)", "Top MD" and "Whos Who in Medicine and Healthcare". Doctor Lawrence H. Einhorn, MD is a published doctor and has 88 publications published. The lastest was: 'Prognostic factors in patients with poor risk germ cell tumors: a retrospective analysis of the Indiana University experience from 1990-2014.' Dr. Lawrence H. Einhorn is registered with Medicare.
Publications
- Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options-An Analysis From the Global Germ Cell Cancer Group.
- Prognostic factors in patients with poor risk germ Cell tumors: a retrospective analysis of the Indiana University experience from 1990-2014.
- Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ Cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier C...
- Small Cell Lung Cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?
- Utilization of sperm banking and barriers to its use in testicular Cancer patients.
- High-Dose Chemotherapy for Recurrent Ovarian Germ Cell Tumors.
- Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130.
- Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular Cancer.
- The Impact of Bleomycin on Retroperitoneal Histology at Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Good Risk Germ Cell Tumors.
- Testicular Cancer: A Reflection on 50 Years of Discovery.
- "Somatic-type" Malignancies Arising From Testicular Germ Cell Tumors: A Clinicopathologic Study of 124 Cases With Emphasis on Glandular Tumors Supporting Frequent Yolk...
- Management of germ Cell tumors with somatic-type malignancy: pathologic features, prognostic factors, and survival outcomes.
- Survival Analysis of Pure Seminoma at Postchemotherapy Retroperitoneal Lymph Node Dissection.
- Pitfalls in Management of Patients With Germ Cell Tumors and Slight Elevation of Serum α-Fetoprotein.
- Barriers to mental health service use and preferences for addressing emotional concerns among lung Cancer patients.
- What are the indications for postchemothearpy retroperitoneal lymph node dissection?
- Why oncologists should support single-payer national health insurance.
- Active surveillance is the preferred approach to clinical stage I testicular Cancer.
- Support service use and interest in support services among lung Cancer patients.
- Support service use and interest in support services among distressed family caregivers of lung Cancer patients.
- Phase II Clinical Trial of Oxaliplatin and Bevacizumab in Refractory Germ Cell Tumors.
- Extragonadal germ Cell tumors: clinical presentation and management.
- A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ Cell tumors.
- Salvage therapy with high-dose chemotherapy and peripheral blood stem Cell transplant in patients with primary mediastinal nonseminomatous germ Cell tumors.
- Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Ant...
- Economic and social changes among distressed family caregivers of lung Cancer patients.
- Updated survival and outcomes for older adults with inoperable stage III non-small-Cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation w...
- The "growing teratoma syndrome" in primary mediastinal nonseminomatous germ Cell tumors: Criteria based on current practice.
- Primary teratoma of the lesser sac: lesser sac teratoma.
- Signet ring Cell carcinoma of the testis: clinicopathologic and molecular evidence for germ Cell tumor origin-a case report.
- Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ Cell tumors: benefit fr...
- Serum tumor markers in testicular Cancer.
- Is retroperitoneal histology predictive of Liver histology at concurrent post-chemotherapy retroperitoneal lymph node dissection and hepatic resection?
- Testicular Cancer survivorship: research strategies and recommendations.
- Primitive neuroectodermal tumors in patients with testicular germ Cell tumors usually resemble pediatric-type central nervous system embryonal neoplasms and lack chrom...
- Salvage Chemotherapy With High-Dose Carboplatin and Etoposide With Peripheral Blood Stem Cell Transplant in Patients With Relapsed Pure Seminoma.
- Perceptions of masculinity and self-image in adolescent and young adult testicular Cancer survivors: implications for romantic and sexual relationships.
- Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ Cell tumors: is a postchemotherapy retroperitoneal lymph n...
- A case of relapsed testicular Cancer initially isolated to the spleen.
- Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
- Multimodality treatment of germ Cell tumors of the mediastinum.
- Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-Cell lu...
- Primary mediastinal germ Cell tumor evolving into an extramedullary acute megakaryoblastic leukemia causing cord compression.
- First-line chemotherapy for non-small-Cell lung cancer: is there a superior regimen based on histology?
- Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
- Delayed effects of whole brain radiotherapy in germ Cell tumor patients with central nervous system metastases.
- Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small Cell lung cancer: a phase II study from the Hoosier Oncology Group.
- Recommendations on the use of 18F-FDG PET in oncology.
- Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
- Is the blood-brain barrier relevant in metastatic germ Cell tumor?
- High-dose chemotherapy and stem-Cell rescue for metastatic germ-Cell tumors.
- Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome.
- Role of the urologist in metastatic testicular Cancer.
- Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ Cell tumors after progression following high-dose chemotherapy with tandem transplant.
- Postoperative chemotherapy for n2 non-small-Cell lung cancer: conclusions are not black and white, but gray.
- Positron emission tomography scans in postchemotherapy seminoma patients with residual masses: a retrospective review from Indiana University Hospital.
- Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ Cell tumors.
- Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients w...
- Will we ever have personalized medicine for non-small Cell lung cancer?
- Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ Cell tumors: is there a preferred regimen?
- Metachronous intracranial germinoma in a patient with a previous primary Mediastinal seminoma.
- Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal Cancer receiving chemotherapy.
- Phase II study of imatinib mesylate in chemotherapy refractory germ Cell tumors expressing KIT.
- Gene expression profiling differentiates germ Cell tumors from other cancers and defines subtype-specific signatures.
- Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ Cell cancer.
- Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
- Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ Cell cancer of testicular origin: analysis of a single-institution experience.
- Weekly paclitaxel and gemcitabine in advanced transitional-Cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study.
- Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian Cancer: a Hoosier Oncology Group (HOG) study.
- Secondary leukemias in refractory germ Cell tumor patients undergoing autologous stem-Cell transplantation using high-dose etoposide.
- Histology in mixed germ Cell tumors. Is there a favorite pairing?
- Outcome of patients with residual germ Cell or non-germ Cell malignancy after resection of primary mediastinal nonseminomatous germ Cell cancer.
- Long-term survival after high-dose salvage chemotherapy for germ Cell malignancies with adverse prognostic variables.
- Prostate carcinoma presenting as multiple pulmonary nodules in an asymptomatic patient with a history of testicular nonseminomatous germ Cell tumor.
- Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular Tumors?
- Assessment of quality of life in outpatients with advanced Cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology ...
- Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ Cell tumors: final analysis of an intergroup trial.
- Mediastinal metastases from testicular nonseminomatous germ Cell tumors: patterns of dissemination and predictors of long-term survival with surgery.
- Update on late relapse of germ Cell tumor: a clinical and molecular analysis.
- American Society of Clinical Oncology 2001 Presidential Initiative: impact of regulatory burdens on quality Cancer care.
- Chemotherapeutic and surgical strategies for germ Cell tumors.
- Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis Cancer.
- The value of platinum compounds in non-small-Cell lung cancer.
- Curing metastatic testicular Cancer.
- Primary chorioCarcinoma of the bladder with the detection of isochromosome 12p.
- Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular Cancer. 1997.
- Very late relapse of germ Cell tumor as a teratoma: a case report and review of the literature.
Schools
Roy J Lucille a Carver College Of Medicine At University Of Iowa
Ind University Hospital
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anemia
- Basal Cell Carcinoma
- Bladder Cancer
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Indianapolis Monthly
- Fellow (FASCO)
- Top MD
- Whos Who in Medicine and Healthcare
Education
-
University of Texas MD Anderson Cancer Center -
Indiana University School of Medicine -
University of Iowa Carver College of Medicine
Drug Facts
| NPI NUMBER | 1588629695 | |
| NPPES Provider LastName | EINHORN | |
| NPPES Provider FirstName | LAWRENCE | |
| NPPES Provider ZIPCode | 462025112 | |
| NPPES Provider State | IN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 194.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 32.0 | |
| Percent Opioid Claims | 16.49 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588629695 |
| Last Name Of The Provider | EINHORN |
| First Name Of The Provider | LAWRENCE |
| View All |
Similar Doctors
|
|
Dr. Anne Greist, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noah M. Hahn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathy D. Miller, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert P. Nelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Attaya Suvannasankha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Walgren, MD |
|
|
Dr. James E. Schroeder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian C. Myre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Travis J. Osterman, DO |
|
|
Dr. Sameer Z. Ahmed, MD |
|
|
Dr. Paul R. Helft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David B. Wilson, MD
This Doctor is OpenDoctor Recommended.
|